Conexeu PreHealth

Chapter 03 · Top performing posts · read 2026-08-20

Twenty posts, read off the live feed, sorted by what they actually earned.

Not a roundup. Every row was opened and read on 20 August 2026. Sort by the last column and the category’s preference is unambiguous: it rewards mechanism and people, and it ignores product copy.

  • 9 Instagram posts
  • 11 LinkedIn posts
  • Sortable
  • Filterable by format

The board

Every post we read, in one table

Filter by platform or format with the chips; sort any numeric column by clicking its header. The gold rows are the two ceiling posts — the highest-performing brand post and the highest-performing personal post we found.

20 of 20 posts

AccountWhat it wasFormatAudienceEngagementsPer 1k followers
@aestheticsbygaldermaGalderma, brand-owned“Let’s go deep with the first proven regenerative biostimulator” — animated cross-section travelling through epidermis, dermis and hypodermisReel — 3D mechanism76,4004,33756.8
@beckerinjectorbrookeInjector, independent“Bio-stimulators aren’t about INSTANT volume, they’re about teaching your skin to act young again”Reel — to camera—550—
@merzaesthetics_usMerz, brand-owned“It’s the science that sets Radiesse apart”Reel — brand science40,90049612.1
@merzaesthetics_usMerz, brand-owned“Share the Radiesse legacy with your patients” — copy written at the practitioner, not the readerReel — trade ask40,900802.0
@revanesseProllenium, brand-owned“POV: you just had your Revanesse moment and can’t stop smiling”Reel — lifestyle POV31,000692.2
@evergreen.mdPractice, independent“Injectable collagen biostimulators vs. hyaluronic acid fillers — what’s the difference?”Reel — comparison—54—
@_cosmeticcoutureClinic, independent“RADIESSE+ — next-level collagen stimulation”, product copy read straight off the labelReel — product recital—23—
sinclair.meaSinclair, brand-owned (MEA)“Skincare 101: let’s talk about Type I collagen” — one static frame with the science in the captionSingle image—6—
dr.anm_Injector, independentRenuva explained in the caption over a before-and-after stillSingle image — B/A—7—
GaldermaCorporate pageFDA approval of Sculptra for cheek wrinkles — a regulatory milestone posted flatImage + link558,8486371.1
MiMedxCorporate pageExclusive US distribution agreement with RegenLab for RegenKit Wound GelText + link—236—
Flemming Ornskov, MDGalderma chair, personal“The menopause symposium at AMWC this morning was a full room, with a clear focus on evidence” — 4,300-woman survey, told in the first personText — personal—225—
Luba Perry, PhDWyss Institute, personal“I’m thrilled to introduce ReConstruct: vascularized tissues for breast reconstruction” — a scientist launching her own programmeVideo — personal—190—
Conexeu Sciences Inc.Us — corporate page“A defining moment. A new chapter.” Nasdaq unveil filmVideo — native74682109.9
Conexeu Sciences Inc.Us — corporate pageCEO Miles Harrison on Stocks to Watch — the GLP-1 tissue-depletion thesisVideo — off-platform link7463344.2
Aroa BiosurgeryRing-1 analog, corporate“Minimal complications. Maximum confidence.” — three clinical bullets and a linkText + link4,565327.0
Conexeu Sciences Inc.Us — corporate pageB.R.E.A.S.T.™ preclinical programme opens at the Wake Forest Institute for Regenerative MedicineText + link7463040.2
Conexeu Sciences Inc.Us — corporate page“Conexeu Sciences Inc. has a new look, but our mission remains the same”Text only7462837.5
Conexeu Sciences Inc.Us — corporate pageCSO Dr Claudia Chavez-Munoz on Progress, Potential, and PossibilitiesVideo — off-platform link7462330.8
Conexeu Sciences Inc.Us — corporate pageThree new directors, a Chief Commercial Officer and an advisory-board appointmentText + link7461114.7

Read off the live posts and profiles on 2026-08-20. ‘Engagements’ is likes plus comments on Instagram and reactions plus comments on LinkedIn, where both were rendered; where a comment count was not shown, the reaction or like count alone is used, which understates those rows. ‘Per 1k followers’ is only computed where the account’s follower count is public — independent injector and practice accounts are left blank rather than guessed.

The pattern

Four findings that hold across both platforms

Mechanism beats results. People beat pages. Product copy loses to everything.

The spread inside a single brand’s own account is larger than the spread between brands. Merz’s science reel earned 12.1 per thousand; Merz’s trade reel earned 2.0. Same account, same quarter, 6× apart. What changed was who the copy was addressed to.

  1. The ceiling is an animation, and it is 4.7× the next brand post. Galderma’s three-layer cross-section at 56.8 per thousand against Merz’s science reel at 12.1. Both are “science” content. One shows the mechanism; the other asserts it.
  2. Individuals out-earn the organisations they work for. Galderma’s chair, writing in the first person about a symposium, pulled 225 engagements. A Wyss scientist introducing her own programme pulled 190 on video. Both beat most of what their institutions posted — and thought-leader distribution runs about 1.6× the engagement rate of the same content on a brand page.
  3. Absolute engagement in this category is small, and that is the good news. MiMedx’s best post in seven months: 236. Aroa Biosurgery’s: 32. Conexeu’s Nasdaq film already did 82. The regenerative-tissue field is not a crowded auction — it is an under-competed one, where a genuinely good post is visible immediately.
  4. Static is over. Every single-image post we read finished in single digits: 7, 6. Both had substantive science in the caption. The format, not the content, was the failure.

Where the two platforms genuinely differ

InstagramLinkedIn
What it ranksCompletion rate and watch timeDwell time and comment depth
Best format, 2026 dataReels for reach (~60–70% of the mix); carousels for saves at 0.50% engagement against Reels’ 0.48%Native document posts at ~7.00%, then multi-image at ~6.45%, then video at ~6.00%
Who wins hereIndependent injectors and patientsNamed individuals with credentials
Conexeu’s realistic jobOwn the mechanism visual. Nobody in the regenerative ring is even trying.Own the preclinical-progress narrative and convert the founders into the channel.
Healthcare / pharma / biotech benchmark1.3% Facebook, format-dependent on IG3.3% engagement
Conexeu today695 followers, 34-day cadence gaps746 followers, median post at ~3.9% — already above benchmark

Format benchmarks from published 2026 datasets (Socialinsider Q2 2026; Buffer’s 52-million-post analysis; Social Media Today on LinkedIn document posts; LinkedIn industry benchmark sets). Conexeu figures read live on 2026-08-20. Note that published benchmarks disagree materially on the carousel-versus-Reel gap — Socialinsider puts it at 0.02 points, Buffer at more than double — because they measure against different denominators. Both agree on the direction.

The three to study

Three posts worth copying the structure of

Instagram

@aestheticsbygalderma

Reel · animated cross-section · 4 Sep 2025

Let’s go deep with the first proven regenerative biostimulator. Sculptra works across all 3 layers of the skin.

Likes
4.3K
Comments
37
Per 1k
56.8

Why it worked

The verb is go deep, and the film delivers on it literally — one continuous descent through named anatomical layers. The promise and the execution are the same gesture.

It gives the finding away rather than teasing it. No link, no “learn more at the link in bio” carrying the payload.

4.3K likes against 37 comments is the signature of a post people watched to the end rather than argued about. Watch time is what got it distributed.

Conexeu’s version

This is Format 01, and Conexeu’s version is stronger on the merits: a scaffold being populated by host cells is a more visually legible event than collagen stimulation, because there is an actual structure on screen. Same descent, three named layers, ending on the lattice filling in.

See the post
LinkedIn

Flemming Ornskov, MD — Galderma chair

Text, first person · ~Apr 2026

The menopause symposium at AMWC this morning was a full room, with a clear focus on evidence.

Reactions
225
Format
Text
Assets
None

Why it worked

No video, no design, no budget. A named senior scientist reporting what he saw in a room that morning, then citing the survey behind it — 4,300 women, five continents.

The structure is: observation, then the evidence gap it closes, then what that changes clinically. It reads as someone thinking, not someone announcing.

It also does something a brand page structurally cannot: it takes a position. Clinicians “lacked a robust evidence base” is a mild criticism of the field, and mild criticism is what makes a post worth reacting to.

Conexeu’s version

Dr Chavez-Munoz has a stronger version of exactly this available every month: what the Wake Forest programme is actually showing, what the field still cannot answer about post-mastectomy reconstruction, and what changes if a scaffold works. Zero production cost, posted from her own profile.

See the post
Instagram

@beckerinjectorbrooke

Reel · to camera · 26 Jan 2025

Bio-stimulators aren’t about INSTANT volume, they’re about teaching your skin to act young again.

Likes
525
Comments
25
Budget
None

Why it worked

One injector with no brand backing beat @revanesse (31k) 8× and @merzaesthetics_us’s trade reel (40.9k) 6.6× on the same subject.

The whole post is a single reframe delivered in the first sentence, and the sentence names the misconception before correcting it — “aren’t about instant volume”.

25 comments on 525 likes is a much higher argument rate than the Galderma animation. Reframes get discussed; demonstrations get watched. A programme needs both.

Conexeu’s version

This is Format 04 and it is the cheapest thing on this page to test. Conexeu’s reframe is one step larger than hers: not “biostimulators are misunderstood” but “there is a third job that neither filling nor stimulating does”.

See the post

One correction to the row above: the comment-to-like ratio comparison is between @beckerinjectorbrooke’s reel and the Galderma animation, not against the category as a whole — comment counts were not rendered on several rows in the read set.